-
公开(公告)号：US20250041266A1
公开(公告)日：2025-02-06
申请号：US18924230
申请日：2024-10-23
Applicant: Novartis AG
Inventor： Philippe Michel Rene BOUILLOT , Frank DAHLKE , Eric LEGANGNEUX , Emeric REYNAUD , Erik WALLSTROM
IPC: A61K31/397 , A61K9/20
Abstract: The present invention relates to siponimod (BAB312) for use in the treatment of an autoimmune disease, wherein an immediate release dosage form is administered once daily to a patient as maintenance regimen and wherein the patient has experienced a specific titration regimen with siponimod beforehand.
Search Results
1
records
(took 0.008 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
